Skip to main content

Ten Bard IVC Filter Cases To Be Remanded Back To Court

Ten Bard IVC Filter Cases To Be Remanded Back To Court

Ten Bard IVC Filter Cases To Be Remanded Back To Court

Introduction

U.S. District Judge David G.  Campbell presiding over C.R. Bard's inferior vena cava filter (IVC) MDL issued an order on July 9, stating ten mature cases would be remanded back to different federal courts for trial as these were already underway when the MDL was established. The parties are required to file a joint summary proposal about the case developments by July 27.

Judge Campbell also mentioned, "The summary generally should chronicle the MDL proceedings, summarize the key MDL legal and evidentiary rulings that will affect the remanded cases, identify any remaining discovery or other pre-trial issues, and estimate the time needed to resolve such issues and make the cases ready for trial.” Though these ten cases were not considered as "bellwethers", the trials would be closely watched by attorneys involved in the litigation, which may affect the settlement values in other claims. In yet another product liability case filed by Carol Kruse against Bard's IVC blood vessel filter, an Arizona jury ordered a summary judgment, stating the statute of limitation expired on the claims and canceled the bellwether trial which was scheduled for September 2018.

C.R. Bard faces numerous lawsuits over complications related to the IVC filter, stating the device is prone to break and injure internal organs. A multidistrict litigation (MDL No.2641; In Re: Bard IVC Filters Products Liability Litigation) was formed for centralized pretrial proceedings in the United States District Court District of Arizona on August 17, 2015.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!